Literature DB >> 447871

An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata.

C H Buckley, H Fox.   

Abstract

A series of five benign and 60 malignant colonorectal neoplasms has been examined immunohistochemically for the presence of HCG. This hormone was not demonstrated in any of the benign tumours but was present in 43% of the malignant neoplasms. The incidence of HCG secretion was unrelated to the sex of the patient but tended to be decreased in patients of advanced age. The HCG-containing tumours, which were predominantly from the left side of the large intestine, had all penetrated the full thickness of the bowel wall while a significant proportion of those tumours lacking HCG were still confined to the bowel wall. Despite the greater degree of local aggressiveness shown by the HCG-secreting tumours there was no correlation between HCG production and the presence of local metastases but, as the presence of HCG is associated with local invasion, it is suggested that preoperative immunohistochemical studies of HCG in biopsies of large bowel neoplasms may be of value in the planning of surgical procedures.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447871      PMCID: PMC1145674          DOI: 10.1136/jcp.32.4.368

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Chorionepithelioma of the stomach.

Authors:  J F REGAN; J H CREMIN
Journal:  Am J Surg       Date:  1960-08       Impact factor: 2.565

2.  Differential effect of pregnancy or gestagens on humoral and cell-mediated immunity.

Authors:  N Fabris; L Piantanelli; M Muzzioli
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin.

Authors:  D C Tormey; T P Waalkes; R M Simon
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

Review 5.  Placental proteins and their subunits as tumor markers.

Authors: 
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

6.  Antigens associated with normal and malignant gastrointestinal tissues.

Authors:  D M Goldenberg; K D Pant; H L Dahlman
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

7.  Human chorionic gonadotropin in human neoplastic cells.

Authors:  L M McManus; M A Naughton; A Martinez-Hernandez
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

8.  Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy.

Authors:  C R Kahn; S W Rosen; B D Weintraub; S S Fajans; P Gorden
Journal:  N Engl J Med       Date:  1977-09-15       Impact factor: 91.245

9.  Significance of alpha-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique.

Authors:  R A Walker
Journal:  J Clin Pathol       Date:  1978-03       Impact factor: 3.411

10.  Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms.

Authors:  S Gailani; T M Chu; A Nussbaum; M Ostrander; N Christoff
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

View more
  11 in total

1.  Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours.

Authors:  P Skrabanek; D Powell; C E Connolly
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

Review 2.  The role of immunocytochemistry in tumour pathology: a review.

Authors:  E Heyderman
Journal:  J R Soc Med       Date:  1980-09       Impact factor: 5.344

3.  Elevated human chorionic gonadotrophin levels in a patient with pancreatic carcinoma presenting with a testicular metastasis.

Authors:  H Taylor; N Heaton; P Farrands; N Kirkham; M Fletcher
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

4.  Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma.

Authors:  K N Syrigos; I Fyssas; M M Konstandoulakis; K J Harrington; S Papadopoulos; N Milingos; P Peveretos; B C Golematis
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

5.  Human chorionic gonadotropin in the rectosigmoid colon. Immunohistochemical study on unbalanced distribution of subunits.

Authors:  M Fukayama; Y Hayashi; M Koike
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

6.  [Significance of serum beta-hCG as a tumor marker for stomach carcinoma].

Authors:  B Rau; C Below; W Haensch; W Liebrich; C von Schilling; P M Schlag
Journal:  Langenbecks Arch Chir       Date:  1995

7.  Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus.

Authors:  Anne Couvelard; François Paraf; Dominique Vidaud; Sylvie Dubois; Michel Vidaud; Jean-François Fléjou; Claude Degott
Journal:  Virchows Arch       Date:  2004-08-10       Impact factor: 4.064

8.  Observer variation in the histological grading of rectal carcinoma.

Authors:  G D Thomas; M F Dixon; N C Smeeton; N S Williams
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis.

Authors:  A Yamaguchi; T Ishida; G Nishimura; T Kumaki; M Katoh; T Kosaka; Y Yonemura; I Miyazaki
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

Review 10.  Primary colon adenocarcinoma with choriocarcinoma differentiation: a case report and review of the literature.

Authors:  Jessica Boyce; Karine Tawagi; John T Cole
Journal:  J Med Case Rep       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.